Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss - BioSpace

Retrieved on: 2023-10-18 18:26:01

Tags for this article:

G protein-coupled receptors

Peptide hormones

Aphrodisiacs

Peptides

Melanocortin 4 receptor

Melanocortin

Anti-diabetic drugs

Glucagon-like peptide-1 receptor agonist

Glucagon-like peptide-1

Bremelanotide

Agouti-related peptide

Obesity

GLP-1

Palatin Technologies Inc.

Click the tags to see associated articles and topics

Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/palatin-announces-positive-preclinical-data-showing-synergistic-weight-loss-initiating-clinical-study-of-melanocortin-4-receptor-agonist-glp-1-in-obese-patients/

Excerpt

... peptide-1 (GLP-1) presented at the Peptide Therapeutics Symposium; GLP-1 ... biotechnology companies, commercial acceptance of Palatin's products ...

Article found on: www.biospace.com

View Original Article